Similar articles for PMID: 28291260

Year	Number of Results
1996	1
2008	2
2009	1
2010	7
2011	2
2012	6
2013	6
2014	3
2015	9
2016	16
2017	11
2018	4
2019	5
2020	4
2021	3
2023	1
2024	0

1

Gene expression and proliferation biomarkers for antidepressant treatment resistance.

Breitfeld J, Scholl C, Steffens M, Laje G, Stingl JC. Breitfeld J, et al. Transl Psychiatry. 2017 Mar 14;7(3):e1061. doi: 10.1038/tp.2017.16. Transl Psychiatry. 2017. PMID: 28291260 Free PMC article.

2

Proliferation rates and gene expression profiles in human lymphoblastoid cell lines from patients with depression characterized in response to antidepressant drug therapy.

Breitfeld J, Scholl C, Steffens M, Brandenburg K, Probst-Schendzielorz K, Efimkina O, Gurwitz D, Ising M, Holsboer F, Lucae S, Stingl JC. Breitfeld J, et al. Transl Psychiatry. 2016 Nov 15;6(11):e950. doi: 10.1038/tp.2016.185. Transl Psychiatry. 2016. PMID: 27845776 Free PMC article.

3

Citalopram-induced pathways regulation and tentative treatment-outcome-predicting biomarkers in lymphoblastoid cell lines from depression patients.

Barakat AK, Scholl C, Steffens M, Brandenburg K, Ising M, Lucae S, Holsboer F, Laje G, Kalayda GV, Jaehde U, Stingl JC. Barakat AK, et al. Transl Psychiatry. 2020 Jul 1;10(1):210. doi: 10.1038/s41398-020-00900-8. Transl Psychiatry. 2020. PMID: 32612257 Free PMC article.

4

CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: results from the Munich Antidepressant Response Signature (MARS) study.

Probst-Schendzielorz K, Scholl C, Efimkina O, Ersfeld E, Viviani R, Serretti A, Fabbri C, Gurwitz D, Lucae S, Ising M, Paul AM, Lehmann ML, Steffens M, Crisafulli C, Calabrò M, Holsboer F, Stingl J. Probst-Schendzielorz K, et al. Pharmacogenomics. 2015;16(7):689-701. doi: 10.2217/pgs.15.31. Epub 2015 May 6. Pharmacogenomics. 2015. PMID: 25943212

5

Gene expression signature of antidepressant treatment response/non-response in Flinders Sensitive Line rats subjected to maternal separation.

Marchetti L, Lauria M, Caberlotto L, Musazzi L, Popoli M, Mathé AA, Domenici E, Carboni L. Marchetti L, et al. Eur Neuropsychopharmacol. 2020 Feb;31:69-85. doi: 10.1016/j.euroneuro.2019.11.004. Epub 2019 Dec 6. Eur Neuropsychopharmacol. 2020. PMID: 31813757

6

Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance.

Fabbri C, Crisafulli C, Calati R, Albani D, Forloni G, Calabrò M, Martines R, Kasper S, Zohar J, Juven-Wetzler A, Souery D, Montgomery S, Mendlewicz J, Serretti A. Fabbri C, et al. Eur Arch Psychiatry Clin Neurosci. 2017 Dec;267(8):723-735. doi: 10.1007/s00406-017-0766-1. Epub 2017 Mar 4. Eur Arch Psychiatry Clin Neurosci. 2017. PMID: 28260126 Clinical Trial.

7

Genome-wide expression profiling of human lymphoblastoid cell lines identifies CHL1 as a putative SSRI antidepressant response biomarker.

Morag A, Pasmanik-Chor M, Oron-Karni V, Rehavi M, Stingl JC, Gurwitz D. Morag A, et al. Pharmacogenomics. 2011 Feb;12(2):171-84. doi: 10.2217/pgs.10.185. Pharmacogenomics. 2011. PMID: 21332311 Free article.

8

Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications.

Fabbri C, Serretti A. Fabbri C, et al. Curr Psychiatry Rep. 2015 Jul;17(7):50. doi: 10.1007/s11920-015-0594-9. Curr Psychiatry Rep. 2015. PMID: 25980509 Review.

9

Essential Contributions of Serotonin Transporter Inhibition to the Acute and Chronic Actions of Fluoxetine and Citalopram in the SERT Met172 Mouse.

Nackenoff AG, Moussa-Tooks AB, McMeekin AM, Veenstra-VanderWeele J, Blakely RD. Nackenoff AG, et al. Neuropsychopharmacology. 2016 Jun;41(7):1733-41. doi: 10.1038/npp.2015.335. Epub 2015 Oct 30. Neuropsychopharmacology. 2016. PMID: 26514584 Free PMC article.

10

Distressing adverse events after antidepressant switch in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial: influence of adverse events during initial treatment with citalopram on development of subsequent adverse events with an alternative antidepressant.

Katz AJ, Dusetzina SB, Farley JF, Ellis AR, Gaynes BN, Castillo WC, Stürmer T, Hansen RA. Katz AJ, et al. Pharmacotherapy. 2012 Mar;32(3):234-43. doi: 10.1002/j.1875-9114.2011.01020.x. Pharmacotherapy. 2012. PMID: 22392456 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

64 results

Results by year